Trademarkia Logo

Canada

C$
INGREZZA Logo (color)
REGISTERED

on 12 Nov 2020

Last Applicant/ Owned by

Neurocrine Biosciences, Inc.

6027 Edgewood Bend CourtSan Diego, CA 92130

US

Serial Number

1956354 filed on 9th Apr 2019

Registration Number

TMA1087464 registered on 12th Nov 2020

Registration expiry Date

12th Nov 2030

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

INGREZZA Logo (color)

Trademark usage description

pharmaceutical preparations for human use for schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, digeorge syndrome, lesch-nyhan Read More

Vienna Information


24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Classification Information


Class [005]
Pharmaceutical preparations for human use for schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and Tourette syndrome, movement disorders, namely, Myoclonus, Huntington's chorea, Levodopa-induced dyskinesia, tardive dyskinesia, dystonia, and tics; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of tardive dyskinesia


Classification kind code

11

Mark Details


Serial Number

1956354

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Sept 2020
Registration Pending
Submitted for opposition 191
on 23rd Sept 2020
Registration Fee Notice Sent
Submitted for opposition 42
on 20th May 2020
Advertised
Submitted for opposition 27
on 5th May 2020
Approval Notice Sent
Submitted for opposition 26
on 5th May 2020
Approved
Submitted for opposition 22
on 2th Jul 2019
Search Recorded
Submitted for opposition 20
on 2th Jul 2019
Examiner's First Report
Submitted for opposition 31
on 12th Apr 2019
Formalized
Submitted for opposition 1
on 10th Apr 2019
Created
Submitted for opposition 30
on 9th Apr 2019
Filed